Induction of CD8<sup>+</sup> immune memory and enhanced inflammation in a skin inflammation model through pre-immunization with inactivated pathogens.

Publication Year: 2024

DOI:
10.1111/cts.13697

PMCID:
PMC10766028

PMID:
38082552

Journal Information

Full Title: Clin Transl Sci

Abbreviation: Clin Transl Sci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"none of the 90 sentinels sampled from the rodent unit in the 2-year period after the studies seroconverted to any pathogen (screening reports available in the repository https://osf io/v9sg3/ ). data availability statement the generated datasets for this study can be found in the open science framework"

Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT A.K.H. declares that he has collaborated with the pharmaceutical industry and received funding from this source, and he is also the owner of a diabetes‐related patent as described at https://ivh.ku.dk/english/employees/?pure=en/persons/107126. C.F. declares that she has been funded partly by QM Diagnostics and LeoPharma. M.F.T. is an employee of QM Diagnostics. S.S. declares that he has collaborated with the pharmaceutical industry and received funding from this source as described at https://ivh.ku.dk/english/employees/?pure=en/persons/102444. C.H.F.H. declares that she has collaborated with the pharmaceutical industry and received funding from this source as described at https://ivh.ku.dk/english/employees/?pure=en/persons/306048. C.B. and J.K. are employees of LeoPharma. All other authors declared no competing interests for this work."

Evidence found in paper:

"FUNDING INFORMATION The study was funded in collaboration between University of Copenhagen, LeoPharma, and QM Diagnostics."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025